Obesity
From the Journals
Belapectin misses endpoints in NASH trial
A post-hoc subgroup analysis suggested a benefit for patients without esophageal varices.
From the Journals
Bariatric surgery may curtail colorectal cancer risk
Conference Coverage
Obesity expert: Time to embrace growing array of options
MAUI, HAWAII - "Gastroenterologists are in the first line of treatment for obesity management."
From the Journals
Adolescent obesity linked with midlife cancer risk
Investigators say teen obesity could be an important intervention target for subsequent cancer prevention.
News from the FDA/CDC
FDA approves weekly contraceptive patch Twirla
The levonorgestrel and ethinyl estradiol contraceptive is contraindicated in obese women.
News from the FDA/CDC
Lorcaserin withdrawn from U.S. market due to cancer risk
The Food and Drug Administration advised health care professionals to stop prescribing and dispensing lorcaserin and to contact patients who are...
From the Journals
Age, race affect preterm birth risk in women with obesity
White and Hispanic women saw a protective effect before age 20, after which obesity became a risk factor, but in black women, the crossover did...
From the Journals
Liver fibrosis scores predict CV event risk associated with NAFLD
NAFLD is associated with a twofold increase in cardiovascular events, and liver fibrosis in NAFLD is associated with a fourfold increase.
Latest News
Fewer interventions after sleeve gastrectomy vs. Roux-en-Y, real-world data show
Balanced by weight loss and health outcomes data, safety results may help inform decision making for prospective patients and physicians,...
Conference Coverage
Bariatric surgery is most effective early in the diabetes trajectory
LOS ANGELES – But in the United States, only about 1% of eligible patients with diabetes undergo the procedure.
News
FDA warns of possible cancer risk with lorcaserin
Results from a clinical trial assessing the drug’s safety showed the possible risk increase.